Density of tumor-associated macrophages correlates with lymph node metastasis in papillary thyroid carcinoma

Thyroid

Volumn 22, Issue 9, 2012, Pages 905-910

  Qing, Wei ^a   Fang, Wei Yuan ^a   Ye, Lei ^a   Shen, Li Yun ^a   Zhang, Xiao Fang ^a   Fei, Xiao Chun ^a   Chen, Xi ^a   Wang, Wei Qing ^a   Li, Xiao Ying ^a   Xiao, Jia Cheng ^a   Ning, Guang ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; CD68 ANTIGEN; INTERLEUKIN 10;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CELL DENSITY; DISEASE ASSOCIATION; FEMALE; GENE MUTATION; GENOTYPE; GOITER; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MALE; PHENOTYPE; PRIORITY JOURNAL; THYROID CARCINOMA; TUMOR ASSOCIATED LEUKOCYTE; TUMOR GROWTH;

ADULT; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; CARCINOMA; CELL COUNT; CELLS, CULTURED; CYTOKINES; FEMALE; GOITER, NODULAR; HUMANS; IMMUNOHISTOCHEMISTRY; LEUKOCYTES, MONONUCLEAR; LYMPHATIC METASTASIS; MACROPHAGES; MALE; MIDDLE AGED; MUTATION; NEOPLASM STAGING; PROTO-ONCOGENE PROTEINS B-RAF; THYROID NEOPLASMS;

EID: 84865591281     PISSN: 10507256     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2011.0452     Document Type: Article

References (28)

1. Davies L, Welch HG 2006 Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA 295:2164-2167.
2. Elisei R, Molinaro E, Agate L, Bottici V, Masserini L, Ceccarelli C, Lippi F, Grasso L, Basolo F, Bevilacqua G, Miccoli P, Di Coscio G, Vitti P, Pacini F, Pinchera A 2010 Are the clinical and pathological features of differentiated thyroid carcinoma really changed over the last 35 years? Study on 4187 patients from a single Italian institution to answer this question. J Clin Endocrinol Metab 95:1516-1527.
3. Mazzaferri EL, Jhiang SM 1994 Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 97:418-428.
4. DeGroot LJ, Kaplan EL, McCormick M, Straus FH 1990 Natural history, treatment, and course of papillary thyroid carcinoma. J Clin Endocrinol Metab 71:414-424.
5. Mazzaferri EL, Kloos RT 2001 Clinical review 128: current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab 86:1447-1463.
6. Sherman SI, Brierley JD, Sperling M, Ain KB, Bigos ST, Cooper DS, Haugen BR, Ho M, Klein I, Ladenson PW, Robbins J, Ross DS, Specker B, Taylor T, Maxon III HR 1998 Prospective multicenter study of thyroid carcinoma treatment: initial analysis of staging and outcome. National Thyroid Cancer Treatment Cooperative Study Registry Group. Cancer 83:1012-1021.
7. Leboulleux S, Rubino C, Baudin E, Caillou B, Hartl DM, Bidart JM, Travagli JP, Schlumberger M 2005 Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosis. J Clin Endocrinol Metab 90:5723-5729.
8. Xing M 2010 Prognostic utility of BRAF mutation in papillary thyroid cancer. Mol Cell Endocrinol 321:86-93.
9. Qian BZ, Pollard JW 2010 Macrophage diversity enhances tumor progression and metastasis. Cell 141:39-51.
10. Ryder M, Ghossein RA, Ricarte-Filho JC, Knauf JA, Fagin JA 2008 Increased density of tumor-associated macrophages is associated with decreased survival in advanced thyroid cancer. Endocr Relat Cancer 15:1069-1074.
11. Caillou B, Talbot M, Weyemi U, Pioche-Durieu C, Al Ghuzlan A, Bidart JM, Chouaib S, Schlumberger M, Dupuy C 2011 Tumor-associated macrophages (TAMs) form an interconnected cellular supportive network in anaplastic thyroid carcinoma. PLoS One 6:e22567.
12. SolinasG, Schiarea S,Liguori M, FabbriM, Pesce S,Zammataro L, Pasqualini F, Nebuloni M, Chiabrando C, Mantovani A, Allavena P 2010 Tumor-conditioned macrophages secrete migration-stimulating factor: a new marker for M2-polarization, influencing tumor cell motility. J Immunol 185:642-652.
13. Sierra JR, Corso S, Caione L, Cepero V, Conrotto P, Cignetti A, Piacibello W, Kumanogoh A, Kikutani H, Comoglio PM, Tamagnone L, Giordano S 2008 Tumor angiogenesis and progression are enhanced by Sema4D produced by tumorassociated macrophages. J Exp Med 205:1673-1685.
14. Duff MD, Mestre J, Maddali S, Yan ZP, Stapleton P, Daly JM 2007 Analysis of gene expression in the tumor-associated macrophage. J Surg Res 142:119-128.
15. Chen JJ, Lin YC, Yao PL, Yuan A, Chen HY, Shun CT, Tsai MF, Chen CH, and Yang PC 2005 Tumor-associated macrophages: the double-edged sword in cancer progression. J Clin Oncol 23:953-964.
16. Zhu XD, Zhang JB, Zhuang PY, Zhu HG, Zhang W, Xiong YQ, Wu WZ, Wang L, Tang ZY, and Sun HC 2008 High expression of macrophage colony-stimulating factor in peritumoral liver tissue is associated with poor survival after curative resection of hepatocellular carcinoma. J Clin Oncol 26:2707-2716.
17. Kim DW, Min HS, Lee KH, Kim YJ, Oh DY, Jeon YK, Lee SH, Im SA, Chung DH, Kim YT, Kim TY, Bang YJ, Sung SW, Kim JH, Heo DS 2008 High tumour islet macrophage infiltration correlates with improved patient survival but not with EGFR mutations, gene copy number or protein expression in resected non-small cell lung cancer. Br J Cancer 98:1118-1124.
18. Fiumara A, Belfiore A, Russo G, Salomone E, Santonocito GM, Ippolito O, Vigneri R, Gangemi P 1997 In situ evidence of neoplastic cell phagocytosis by macrophages in papillary thyroid cancer. J Clin Endocrinol Metab 82:1615-1620.
19. Mantovani A, Sozzani S, Locati M, Allavena P, Sica A 2002 Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 23:549-555.
20. Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M 2004 The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 25:677-686.
21. Buechler C, Ritter M, Orsó E, Langmann T, Klucken J, Schmitz G 2000 Regulation of scavenger receptor CD163 expression in human monocytes and macrophages by proand antiinflammatory stimuli. J Leukoc Biol 67:97-103.
22. Sica A, Saccani A, Bottazzi B, Polentarutti N, Vecchi A, van Damme J, Mantovani A 2000 Autocrine production of IL-10 mediates defective IL-12 production and NF-kappa B activation in tumor-associated macrophages. J Immunol 164: 762-767.
23. Mantovani A, Schioppa T, Porta C, Allavena P, Sica A 2006 Role of tumor-associated macrophages in tumor progression and invasion. Cancer Metastasis Rev 25:315-322.
24. Mukhtar RA, Moore AP, Nseyo O, Baehner FL, Au A, Moore DH, Twomey P, Campbell MJ, Esserman LJ 2011 Elevated PCNA+ tumor-associated macrophages in breast cancer are associated with early recurrence and non-Caucasian ethnicity. Breast Cancer Res Treat 130:635-644.
25. Lewis CE, Leek R, Harris A, McGee JO 1995 Cytokine regulation of angiogenesis in breast cancer: the role of tumorassociated macrophages. J Leukoc Biol 57:747-751.
26. Biswas SK, Gangi L, Paul S, Schioppa T, Saccani A, Sironi M, Bottazzi B, Doni A, Vincenzo B, Pasqualini F, Vago L, Nebuloni M, Mantovani A, Sica A 2006A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-kappaB and enhanced IRF-3/ STAT1 activation). Blood 107:2112-2122.
27. Pollard JW 2009 Trophic macrophages in development and disease. Nat Rev Immunol 9:259-270.
28. Melillo RM, Castellone MD, Guarino V, De Falco V, Cirafici AM, Salvatore G, Caiazzo F, Basolo F, Giannini R, Kruhoffer M, Orntoft T, Fusco A, Santoro M 2005 The RET/PTC-RASBRAF linear signaling cascade mediates the motile and mitogenic phenotype of thyroid cancer cells. J Clin Invest 115:1068-1081.